Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Liquidia Corporation - Common Stock
(NQ:
LQDA
)
55.23
-3.52 (-5.98%)
Streaming Delayed Price
Updated: 2:23 PM EDT, Jun 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Liquidia Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Breaking Down Liquidia: 4 Analysts Share Their Views
↗
April 10, 2025
Via
Benzinga
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
April 01, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
April 01, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
March 28, 2025
FDA sets PDUFA goal date of May 24, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Breaking Down Liquidia: 4 Analysts Share Their Views
↗
January 09, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference
May 06, 2025
From
Liquidia Corporation
Via
GlobeNewswire
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
May 02, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025
May 01, 2025
From
Liquidia Corporation
Via
GlobeNewswire
The Analyst Landscape: 11 Takes On Liquidia
↗
November 14, 2024
Via
Benzinga
Earnings Scheduled For November 13, 2024
↗
November 13, 2024
Via
Benzinga
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
March 27, 2025
From
Liquidia Corporation
Via
GlobeNewswire
What 4 Analyst Ratings Have To Say About Liquidia
↗
March 20, 2025
Via
Benzinga
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday
↗
March 20, 2025
Via
Benzinga
Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update
March 19, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Uncovering Potential: Liquidia's Earnings Preview
↗
November 12, 2024
Via
Benzinga
Evaluating Liquidia: Insights From 14 Financial Analysts
↗
October 03, 2024
Via
Benzinga
Earnings Scheduled For March 19, 2025
↗
March 19, 2025
Via
Benzinga
Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million
March 18, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
March 12, 2025
From
Liquidia Corporation
Via
GlobeNewswire
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
February 24, 2025
From
Atea Pharmaceuticals, Inc.
Via
GlobeNewswire
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025
From
Liquidia Corporation
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 26, 2024
Via
Benzinga
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia to Present at the Stifel 2024 Healthcare Conference
November 12, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
November 06, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
November 04, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
↗
October 07, 2024
Via
Benzinga
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
October 07, 2024
From
Liquidia Corporation
Via
GlobeNewswire
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
October 02, 2024
From
Liquidia Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
